Myc (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Myc" in Galician language version.

Last modified: 00:19:34, 25 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank Galician rank

10081nih.gov

5^th place

2^nd place

9980doi.org

2^nd place

3^rd place

4835archive.org

6^th place

4^th place

1515adsabs.harvard.edu

14^th place

17^th place

22web.archive.org

1^st place

11reuters.com

38^th place

97^th place

11uzh.ch

1,380^th place

1,523^rd place

11man.ac.uk

low place

3,330^th place

11myscience.org.uk

low place

11ebi.ac.uk

4,422^nd place

464^th place

adsabs.harvard.edu (Global: 14^th place; Galician: 17^th place)

Finver SN, Nishikura K, Finger LR, Haluska FG, Finan J, Nowell PC, Croce CM (maio de 1988). "Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered". Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. Bibcode:1988PNAS...85.3052F. PMC 280141. PMID 2834731. doi:10.1073/pnas.85.9.3052.
Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R (xullo de 2007). "Non-transcriptional control of DNA replication by c-Myc". Nature 448 (7152): 445–51. Bibcode:2007Natur.448..445D. PMID 17597761. doi:10.1038/nature05953.
Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV (xullo de 2008). "Global regulation of nucleotide biosynthetic genes by c-Myc". PLOS ONE 3 (7): e2722. Bibcode:2008PLoSO...3.2722L. PMC 2444028. PMID 18628958. doi:10.1371/journal.pone.0002722.
Clavería C, Giovinazzo G, Sierra R, Torres M (agosto de 2013). "Myc-driven endogenous cell competition in the early mammalian embryo". Nature 500 (7460): 39–44. Bibcode:2013Natur.500...39C. PMID 23842495. doi:10.1038/nature12389.
Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, Elledge SJ, Westbrook TF (xaneiro de 2012). "A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis". Science 335 (6066): 348–53. Bibcode:2012Sci...335..348K. PMC 4059214. PMID 22157079. doi:10.1126/science.1212728. Erro no estilo Vancouver: wikilink (Axuda)
Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV, Buchanan S, Peng SB, Staschke KA, Yadav V, Yue Y, Kouros-Mehr H (2014). "Identification of druggable cancer driver genes amplified across TCGA datasets". PLOS ONE 9 (5): e98293. Bibcode:2014PLoSO...998293C. PMC 4038530. PMID 24874471. doi:10.1371/journal.pone.0098293.
Land H, Parada LF, Weinberg RA (1983). "Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes". Nature 304 (5927): 596–602. Bibcode:1983Natur.304..596L. PMID 6308472. doi:10.1038/304596a0.
Fowler T, Ghatak P, Price DH, Conaway R, Conaway J, Chiang CM, Bradner JE, Shilatifard A, Roy AL (2014). "Regulation of MYC expression and differential JQ1 sensitivity in cancer cells". PLOS ONE 9 (1): e87003. Bibcode:2014PLoSO...987003F. PMC 3900694. PMID 24466310. doi:10.1371/journal.pone.0087003.
Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, et al. (June 2016). "Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells". Nature 534 (7607): 341–6. Bibcode:2016Natur.534..341A. PMC 4913876. PMID 27281222. doi:10.1038/nature18288. ^{[Ligazón morta]}
Roy AL, Carruthers C, Gutjahr T, Roeder RG (setembro de 1993). "Direct role for Myc in transcription initiation mediated by interactions with TFII-I". Nature 365 (6444): 359–61. Bibcode:1993Natur.365..359R. PMID 8377829. doi:10.1038/365359a0.
Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (xullo de 1997). "Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase". Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. Bibcode:1997PNAS...94.7337T. PMC 23822. PMID 9207092. doi:10.1073/pnas.94.14.7337.
Blackwood EM, Eisenman RN (marzo de 1991). "Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc". Science 251 (4998): 1211–7. Bibcode:1991Sci...251.1211B. PMID 2006410. doi:10.1126/science.2006410.
Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP (outubro de 2002). "JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors". Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. Bibcode:2002PNAS...9914189L. PMC 137859. PMID 12391307. doi:10.1073/pnas.232310199.
Guo Q, Xie J, Dang CV, Liu ET, Bishop JM (agosto de 1998). "Identification of a large Myc-binding protein that contains RCC1-like repeats". Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. Bibcode:1998PNAS...95.9172G. PMC 21311. PMID 9689053. doi:10.1073/pnas.95.16.9172.
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (decembro de 1993). "Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc". Science 262 (5141): 1889–92. Bibcode:1993Sci...262.1889S. PMID 8266081. doi:10.1126/science.8266081.

archive.org (Global: 6^th place; Galician: 4^th place)

Finver SN, Nishikura K, Finger LR, Haluska FG, Finan J, Nowell PC, Croce CM (maio de 1988). "Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered". Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. Bibcode:1988PNAS...85.3052F. PMC 280141. PMID 2834731. doi:10.1073/pnas.85.9.3052.
Gearhart J, Pashos EE, Prasad MK (outubro de 2007). "Pluripotency redux--advances in stem-cell research". The New England Journal of Medicine 357 (15): 1469–72. PMID 17928593. doi:10.1056/NEJMp078126.
Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R (xullo de 2007). "Non-transcriptional control of DNA replication by c-Myc". Nature 448 (7152): 445–51. Bibcode:2007Natur.448..445D. PMID 17597761. doi:10.1038/nature05953.
Denis N, Kitzis A, Kruh J, Dautry F, Corcos D (agosto de 1991). "Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc". Oncogene 6 (8): 1453–7. PMID 1886715.
Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984). "Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation". Cell 36 (2): 241–7. PMID 6692471. doi:10.1016/0092-8674(84)90217-4.
Clavería C, Giovinazzo G, Sierra R, Torres M (agosto de 2013). "Myc-driven endogenous cell competition in the early mammalian embryo". Nature 500 (7460): 39–44. Bibcode:2013Natur.500...39C. PMID 23842495. doi:10.1038/nature12389.
Mendell JT (abril de 2008). "miRiad roles for the miR-17-92 cluster in development and disease". Cell 133 (2): 217–22. PMC 2732113. PMID 18423194. doi:10.1016/j.cell.2008.04.001.
Conacci-Sorrell M, Ngouenet C, Eisenman RN (agosto de 2010). "Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation". Cell 142 (3): 480–93. PMC 2923036. PMID 20691906. doi:10.1016/j.cell.2010.06.037.
Land H, Parada LF, Weinberg RA (1983). "Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes". Nature 304 (5927): 596–602. Bibcode:1983Natur.304..596L. PMID 6308472. doi:10.1038/304596a0.
Radner H, el-Shabrawi Y, Eibl RH, Brüstle O, Kenner L, Kleihues P, Wiestler OD (1993). "Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose". Acta Neuropathologica 86 (5): 456–65. PMID 8310796. doi:10.1007/bf00228580.
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (September 2011). "BET bromodomain inhibition as a therapeutic strategy to target c-Myc". Cell 146 (6): 904–17. PMC 3187920. PMID 21889194. doi:10.1016/j.cell.2011.08.017.
Slizynska H (maio de 1938). "Salivary Chromosome Analysis of the White-Facet Region of Drosophila Melanogaster". Genetics 23 (3): 291–9. PMC 1209013. PMID 17246888. doi:10.1093/genetics/23.3.291.
de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA (abril de 2004). "Drosophila myc regulates organ size by inducing cell competition". Cell 117 (1): 107–16. PMID 15066286. doi:10.1016/S0092-8674(04)00214-4.
Park J, Wood MA, Cole MD (marzo de 2002). "BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation". Molecular and Cellular Biology 22 (5): 1307–16. PMC 134713. PMID 11839798. doi:10.1128/mcb.22.5.1307-1316.2002.
Li H, Lee TH, Avraham H (xuño de 2002). "A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer". The Journal of Biological Chemistry 277 (23): 20965–73. PMID 11916966. doi:10.1074/jbc.M112231200.
Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM (decembro de 2003). "BRCA1 inhibition of telomerase activity in cultured cells". Molecular and Cellular Biology 23 (23): 8668–90. PMC 262673. PMID 14612409. doi:10.1128/mcb.23.23.8668-8690.2003.
Zhou C, Liu J (marzo de 2003). "Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells". Biochemical and Biophysical Research Communications 303 (1): 130–6. PMID 12646176. doi:10.1016/s0006-291x(03)00318-8.
Jin Z, Gao F, Flagg T, Deng X (setembro de 2004). "Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation". The Journal of Biological Chemistry 279 (38): 40209–19. PMID 15210690. doi:10.1074/jbc.M404056200.
Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM (agosto de 2001). "The p400 complex is an essential E1A transformation target". Cell 106 (3): 297–307. PMID 11509179. doi:10.1016/s0092-8674(01)00450-0.
Roy AL, Carruthers C, Gutjahr T, Roeder RG (setembro de 1993). "Direct role for Myc in transcription initiation mediated by interactions with TFII-I". Nature 365 (6444): 359–61. Bibcode:1993Natur.365..359R. PMID 8377829. doi:10.1038/365359a0.
Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ, Antsaklis AI, Baxevanis CN, Papamichail M (maio de 2005). "CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells". The Journal of Biological Chemistry 280 (20): 20086–93. PMID 15769738. doi:10.1074/jbc.M410036200.
Gupta S, Davis RJ (outubro de 1994). "MAP kinase binds to the NH2-terminal activation domain of c-Myc". FEBS Letters 353 (3): 281–5. PMID 7957875. doi:10.1016/0014-5793(94)01052-8.
Noguchi K, Kitanaka C, Yamana H, Kokubu A, Mochizuki T, Kuchino Y (novembro de 1999). "Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase". The Journal of Biological Chemistry 274 (46): 32580–7. PMID 10551811. doi:10.1074/jbc.274.46.32580.
McMahon SB, Wood MA, Cole MD (xaneiro de 2000). "The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc". Molecular and Cellular Biology 20 (2): 556–62. PMC 85131. PMID 10611234. doi:10.1128/mcb.20.2.556-562.2000.
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD (agosto de 1998). "The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins". Cell 94 (3): 363–74. PMID 9708738. doi:10.1016/s0092-8674(00)81479-8.
Blackwood EM, Eisenman RN (marzo de 1991). "Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc". Science 251 (4998): 1211–7. Bibcode:1991Sci...251.1211B. PMID 2006410. doi:10.1126/science.2006410.
Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP (outubro de 2002). "JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors". Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. Bibcode:2002PNAS...9914189L. PMC 137859. PMID 12391307. doi:10.1073/pnas.232310199.
Billin AN, Eilers AL, Queva C, Ayer DE (decembro de 1999). "Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors". The Journal of Biological Chemistry 274 (51): 36344–50. PMID 10593926. doi:10.1074/jbc.274.51.36344.
Nair SK, Burley SK (xaneiro de 2003). "X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors". Cell 112 (2): 193–205. PMID 12553908. doi:10.1016/s0092-8674(02)01284-9.
Taira T, Sawai M, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H (agosto de 1999). "Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y". The Journal of Biological Chemistry 274 (34): 24270–9. PMID 10446203. doi:10.1074/jbc.274.34.24270.
Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M, Yasumoto K, Funa K, Kohno K (agosto de 2002). "p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression". The Journal of Biological Chemistry 277 (35): 31694–702. PMID 12080043. doi:10.1074/jbc.M200266200.
Liu X, Tesfai J, Evrard YA, Dent SY, Martinez E (maio de 2003). "c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation". The Journal of Biological Chemistry 278 (22): 20405–12. PMC 4031917. PMID 12660246. doi:10.1074/jbc.M211795200.
Mori K, Maeda Y, Kitaura H, Taira T, Iguchi-Ariga SM, Ariga H (novembro de 1998). "MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc". The Journal of Biological Chemistry 273 (45): 29794–800. PMID 9792694. doi:10.1074/jbc.273.45.29794.
Otsuki Y, Tanaka M, Kamo T, Kitanaka C, Kuchino Y, Sugimura H (febreiro de 2003). "Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts". The Journal of Biological Chemistry 278 (7): 5132–40. PMID 12446731. doi:10.1074/jbc.M206733200.
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (decembro de 1993). "Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc". Science 262 (5141): 1889–92. Bibcode:1993Sci...262.1889S. PMID 8266081. doi:10.1126/science.8266081.

doi.org (Global: 2^nd place; Galician: 3^rd place)

dx.doi.org

Finver SN, Nishikura K, Finger LR, Haluska FG, Finan J, Nowell PC, Croce CM (maio de 1988). "Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered". Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. Bibcode:1988PNAS...85.3052F. PMC 280141. PMID 2834731. doi:10.1073/pnas.85.9.3052.
Carabet LA, Rennie PS, Cherkasov A (decembro de 2018). "Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches". International Journal of Molecular Sciences 20 (1): 120. PMC 6337544. PMID 30597997. doi:10.3390/ijms20010120.
Dang CV, Reddy EP, Shokat KM, Soucek L (agosto de 2017). "Drugging the 'undruggable' cancer targets". Nature Reviews. Cancer 17 (8): 502–508. PMC 5945194. PMID 28643779. doi:10.1038/nrc.2017.36.
Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (setembro de 2012). "c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells". Cell 151 (1): 68–79. PMC 3471363. PMID 23021216. doi:10.1016/j.cell.2012.08.033.
Gearhart J, Pashos EE, Prasad MK (outubro de 2007). "Pluripotency redux--advances in stem-cell research". The New England Journal of Medicine 357 (15): 1469–72. PMID 17928593. doi:10.1056/NEJMp078126.
Cotterman R, Jin VX, Krig SR, Lemen JM, Wey A, Farnham PJ, Knoepfler PS (decembro de 2008). "N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor". Cancer Research 68 (23): 9654–62. PMC 2637654. PMID 19047142. doi:10.1158/0008-5472.CAN-08-1961.
Wolf E, Eilers M (2020). "Targeting MYC Proteins for Tumor Therapy". Annual Review of Cancer Biology 4: 61–75. doi:10.1146/annurev-cancerbio-030518-055826.
Rahl PB, Young RA (xaneiro de 2014). "MYC and transcription elongation". Cold Spring Harbor Perspectives in Medicine 4 (1): a020990. PMC 3869279. PMID 24384817. doi:10.1101/cshperspect.a020990.
Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R (xullo de 2007). "Non-transcriptional control of DNA replication by c-Myc". Nature 448 (7152): 445–51. Bibcode:2007Natur.448..445D. PMID 17597761. doi:10.1038/nature05953.
Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984). "Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation". Cell 36 (2): 241–7. PMID 6692471. doi:10.1016/0092-8674(84)90217-4.
Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV (xullo de 2008). "Global regulation of nucleotide biosynthetic genes by c-Myc". PLOS ONE 3 (7): e2722. Bibcode:2008PLoSO...3.2722L. PMC 2444028. PMID 18628958. doi:10.1371/journal.pone.0002722.
Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG, Mathews CK, Shewach DS, Nikiforov MA (agosto de 2008). "Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells". Cell Cycle 7 (15): 2392–400. PMC 3744895. PMID 18677108. doi:10.4161/cc.6390.
Aughey GN, Grice SJ, Liu JL (febreiro de 2016). "The Interplay between Myc and CTP Synthase in Drosophila". PLOS Genetics 12 (2): e1005867. PMC 4759343. PMID 26889675. doi:10.1371/journal.pgen.1005867.
Clavería C, Giovinazzo G, Sierra R, Torres M (agosto de 2013). "Myc-driven endogenous cell competition in the early mammalian embryo". Nature 500 (7460): 39–44. Bibcode:2013Natur.500...39C. PMID 23842495. doi:10.1038/nature12389.
de Alboran IM, O'Hagan RC, Gärtner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA, Alt FW (xaneiro de 2001). "Analysis of C-MYC function in normal cells via conditional gene-targeted mutation". Immunity 14 (1): 45–55. PMID 11163229. doi:10.1016/S1074-7613(01)00088-7.
Mendell JT (abril de 2008). "miRiad roles for the miR-17-92 cluster in development and disease". Cell 133 (2): 217–22. PMC 2732113. PMID 18423194. doi:10.1016/j.cell.2008.04.001.
Conacci-Sorrell M, Ngouenet C, Eisenman RN (agosto de 2010). "Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation". Cell 142 (3): 480–93. PMC 2923036. PMID 20691906. doi:10.1016/j.cell.2010.06.037.
Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, Elledge SJ, Westbrook TF (xaneiro de 2012). "A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis". Science 335 (6066): 348–53. Bibcode:2012Sci...335..348K. PMC 4059214. PMID 22157079. doi:10.1126/science.1212728. Erro no estilo Vancouver: wikilink (Axuda)
Ross JS, Ali SM, Wang K, Palmer G, Yelensky R, Lipson D, Miller VA, Zajchowski D, Shawver LK, Stephens PJ (setembro de 2013). "Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies". Gynecologic Oncology 130 (3): 554–9. PMID 23791828. doi:10.1016/j.ygyno.2013.06.019.
Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV, Buchanan S, Peng SB, Staschke KA, Yadav V, Yue Y, Kouros-Mehr H (2014). "Identification of druggable cancer driver genes amplified across TCGA datasets". PLOS ONE 9 (5): e98293. Bibcode:2014PLoSO...998293C. PMC 4038530. PMID 24874471. doi:10.1371/journal.pone.0098293.
Land H, Parada LF, Weinberg RA (1983). "Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes". Nature 304 (5927): 596–602. Bibcode:1983Natur.304..596L. PMID 6308472. doi:10.1038/304596a0.
Radner H, el-Shabrawi Y, Eibl RH, Brüstle O, Kenner L, Kleihues P, Wiestler OD (1993). "Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose". Acta Neuropathologica 86 (5): 456–65. PMID 8310796. doi:10.1007/bf00228580.
Fowler T, Ghatak P, Price DH, Conaway R, Conaway J, Chiang CM, Bradner JE, Shilatifard A, Roy AL (2014). "Regulation of MYC expression and differential JQ1 sensitivity in cancer cells". PLOS ONE 9 (1): e87003. Bibcode:2014PLoSO...987003F. PMC 3900694. PMID 24466310. doi:10.1371/journal.pone.0087003.
Shi J, Vakoc CR (xuño de 2014). "The mechanisms behind the therapeutic activity of BET bromodomain inhibition". Molecular Cell 54 (5): 728–36. PMC 4236231. PMID 24905006. doi:10.1016/j.molcel.2014.05.016.
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (September 2011). "BET bromodomain inhibition as a therapeutic strategy to target c-Myc". Cell 146 (6): 904–17. PMC 3187920. PMID 21889194. doi:10.1016/j.cell.2011.08.017.
Stasevich EM, Murashko MM, Zinevich LS, Demin DE, Schwartz AM (xullo de 2021). "The Role of Non-Coding RNAs in the Regulation of the Proto-Oncogene MYC in Different Types of Cancer". Biomedicines 9 (8): 921. PMC 8389562. PMID 34440124. doi:10.3390/biomedicines9080921.
Slizynska H (maio de 1938). "Salivary Chromosome Analysis of the White-Facet Region of Drosophila Melanogaster". Genetics 23 (3): 291–9. PMC 1209013. PMID 17246888. doi:10.1093/genetics/23.3.291.
de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA (abril de 2004). "Drosophila myc regulates organ size by inducing cell competition". Cell 117 (1): 107–16. PMID 15066286. doi:10.1016/S0092-8674(04)00214-4.
Maines JZ, Stevens LM, Tong X, Stein D (febreiro de 2004). "Drosophila dMyc is required for ovary cell growth and endoreplication". Development 131 (4): 775–86. PMID 14724122. doi:10.1242/dev.00932.
Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P (setembro de 1999). "Drosophila myc regulates cellular growth during development" (PDF). Cell 98 (6): 779–90. PMID 10499795. doi:10.1016/S0092-8674(00)81512-3. Arquivado dende o orixinal (PDF) o 03 de abril de 2022. Consultado o 13 de setembro de 2023.
Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, et al. (June 2016). "Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells". Nature 534 (7607): 341–6. Bibcode:2016Natur.534..341A. PMC 4913876. PMID 27281222. doi:10.1038/nature18288. ^{[Ligazón morta]}
Knoepfler PS, Cheng PF, Eisenman RN (outubro de 2002). "N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation". Genes & Development 16 (20): 2699–712. PMC 187459. PMID 12381668. doi:10.1101/gad.1021202.
Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, et al. (novembro de 2004). "c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation". Genes & Development 18 (22): 2747–63. PMC 528895. PMID 15545632. doi:10.1101/gad.313104.
Takahashi K, Yamanaka S (marzo de 2016). "A decade of transcription factor-mediated reprogramming to pluripotency". Nature Reviews. Molecular Cell Biology 17 (3): 183–93. PMID 26883003. doi:10.1038/nrm.2016.8.
Park J, Wood MA, Cole MD (marzo de 2002). "BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation". Molecular and Cellular Biology 22 (5): 1307–16. PMC 134713. PMID 11839798. doi:10.1128/mcb.22.5.1307-1316.2002.
Li H, Lee TH, Avraham H (xuño de 2002). "A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer". The Journal of Biological Chemistry 277 (23): 20965–73. PMID 11916966. doi:10.1074/jbc.M112231200.
Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM (decembro de 2003). "BRCA1 inhibition of telomerase activity in cultured cells". Molecular and Cellular Biology 23 (23): 8668–90. PMC 262673. PMID 14612409. doi:10.1128/mcb.23.23.8668-8690.2003.
Zhou C, Liu J (marzo de 2003). "Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells". Biochemical and Biophysical Research Communications 303 (1): 130–6. PMID 12646176. doi:10.1016/s0006-291x(03)00318-8.
Wang Q, Zhang H, Kajino K, Greene MI (outubro de 1998). "BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells". Oncogene 17 (15): 1939–48. PMID 9788437. doi:10.1038/sj.onc.1202403.
Jin Z, Gao F, Flagg T, Deng X (setembro de 2004). "Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation". The Journal of Biological Chemistry 279 (38): 40209–19. PMID 15210690. doi:10.1074/jbc.M404056200.
Kanazawa S, Soucek L, Evan G, Okamoto T, Peterlin BM (agosto de 2003). "c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis". Oncogene 22 (36): 5707–11. PMID 12944920. doi:10.1038/sj.onc.1206800.
Dingar D, Kalkat M, Chan PK, Srikumar T, Bailey SD, Tu WB, Coyaud E, Ponzielli R, Kolyar M, Jurisica I, Huang A, Lupien M, Penn LZ, Raught B (abril de 2015). "BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors". Journal of Proteomics 118 (12): 95–111. PMID 25452129. doi:10.1016/j.jprot.2014.09.029.
Brenner C, Deplus R, Didelot C, Loriot A, Viré E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T, Pelicci PG, Amati B, Kouzarides T, de Launoit Y, Di Croce L, Fuks F (xaneiro de 2005). "Myc represses transcription through recruitment of DNA methyltransferase corepressor". The EMBO Journal 24 (2): 336–46. PMC 545804. PMID 15616584. doi:10.1038/sj.emboj.7600509.
Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM (agosto de 2001). "The p400 complex is an essential E1A transformation target". Cell 106 (3): 297–307. PMID 11509179. doi:10.1016/s0092-8674(01)00450-0.
Roy AL, Carruthers C, Gutjahr T, Roeder RG (setembro de 1993). "Direct role for Myc in transcription initiation mediated by interactions with TFII-I". Nature 365 (6444): 359–61. Bibcode:1993Natur.365..359R. PMID 8377829. doi:10.1038/365359a0.
Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B (xuño de 2003). "MYC recruits the TIP60 histone acetyltransferase complex to chromatin". EMBO Reports 4 (6): 575–80. PMC 1319201. PMID 12776177. doi:10.1038/sj.embor.embor861.
Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT (xaneiro de 2008). "Widespread microRNA repression by Myc contributes to tumorigenesis". Nature Genetics 40 (1): 43–50. PMC 2628762. PMID 18066065. doi:10.1038/ng.2007.30.
Koscianska E, Baev V, Skreka K, Oikonomaki K, Rusinov V, Tabler M, Kalantidis K (2007). "Prediction and preliminary validation of oncogene regulation by miRNAs". BMC Molecular Biology 8: 79. PMC 2096627. PMID 17877811. doi:10.1186/1471-2199-8-79.
Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ, Antsaklis AI, Baxevanis CN, Papamichail M (maio de 2005). "CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells". The Journal of Biological Chemistry 280 (20): 20086–93. PMID 15769738. doi:10.1074/jbc.M410036200.
Gupta S, Davis RJ (outubro de 1994). "MAP kinase binds to the NH2-terminal activation domain of c-Myc". FEBS Letters 353 (3): 281–5. PMID 7957875. doi:10.1016/0014-5793(94)01052-8.
Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (xullo de 1997). "Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase". Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. Bibcode:1997PNAS...94.7337T. PMC 23822. PMID 9207092. doi:10.1073/pnas.94.14.7337.
Noguchi K, Kitanaka C, Yamana H, Kokubu A, Mochizuki T, Kuchino Y (novembro de 1999). "Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase". The Journal of Biological Chemistry 274 (46): 32580–7. PMID 10551811. doi:10.1074/jbc.274.46.32580.
Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology 3: 89. PMC 1847948. PMID 17353931. doi:10.1038/msb4100134.
McMahon SB, Wood MA, Cole MD (xaneiro de 2000). "The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc". Molecular and Cellular Biology 20 (2): 556–62. PMC 85131. PMID 10611234. doi:10.1128/mcb.20.2.556-562.2000.
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD (agosto de 1998). "The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins". Cell 94 (3): 363–74. PMID 9708738. doi:10.1016/s0092-8674(00)81479-8.
Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV (maio de 1999). "c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function". Nature Genetics 22 (1): 102–5. PMID 10319872. doi:10.1038/8811.
Mac Partlin M, Homer E, Robinson H, McCormick CJ, Crouch DH, Durant ST, Matheson EC, Hall AG, Gillespie DA, Brown R (febeiro de 2003). "Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX". Oncogene 22 (6): 819–25. PMID 12584560. doi:10.1038/sj.onc.1206252.
Blackwood EM, Eisenman RN (marzo de 1991). "Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc". Science 251 (4998): 1211–7. Bibcode:1991Sci...251.1211B. PMID 2006410. doi:10.1126/science.2006410.
Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP (outubro de 2002). "JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors". Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. Bibcode:2002PNAS...9914189L. PMC 137859. PMID 12391307. doi:10.1073/pnas.232310199.
Billin AN, Eilers AL, Queva C, Ayer DE (decembro de 1999). "Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors". The Journal of Biological Chemistry 274 (51): 36344–50. PMID 10593926. doi:10.1074/jbc.274.51.36344.
Gupta K, Anand G, Yin X, Grove L, Prochownik EV (marzo de 1998). "Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc". Oncogene 16 (9): 1149–59. PMID 9528857. doi:10.1038/sj.onc.1201634.
Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Lo Nigro C, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A, Carrozzo R (maio de 1997). "Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor". The EMBO Journal 16 (10): 2892–906. PMC 1169897. PMID 9184233. doi:10.1093/emboj/16.10.2892.
Nair SK, Burley SK (xaneiro de 2003). "X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors". Cell 112 (2): 193–205. PMID 12553908. doi:10.1016/s0092-8674(02)01284-9.
FitzGerald MJ, Arsura M, Bellas RE, Yang W, Wu M, Chin L, Mann KK, DePinho RA, Sonenshein GE (abril de 1999). "Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc". Oncogene 18 (15): 2489–98. PMID 10229200. doi:10.1038/sj.onc.1202611.
Meroni G, Cairo S, Merla G, Messali S, Brent R, Ballabio A, Reymond A (xullo de 2000). "Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?". Oncogene 19 (29): 3266–77. PMID 10918583. doi:10.1038/sj.onc.1203634.
Guo Q, Xie J, Dang CV, Liu ET, Bishop JM (agosto de 1998). "Identification of a large Myc-binding protein that contains RCC1-like repeats". Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. Bibcode:1998PNAS...95.9172G. PMC 21311. PMID 9689053. doi:10.1073/pnas.95.16.9172.
Taira T, Maëda J, Onishi T, Kitaura H, Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H (agosto de 1998). "AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC". Genes to Cells 3 (8): 549–65. PMID 9797456. doi:10.1046/j.1365-2443.1998.00206.x.
Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K (abril de 2001). "Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor". Journal of Cell Science 114 (Pt 8): 1533–44. PMID 11282029. doi:10.1242/jcs.114.8.1533.
Taira T, Sawai M, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H (agosto de 1999). "Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y". The Journal of Biological Chemistry 274 (34): 24270–9. PMID 10446203. doi:10.1074/jbc.274.34.24270.
Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M, Yasumoto K, Funa K, Kohno K (agosto de 2002). "p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression". The Journal of Biological Chemistry 277 (35): 31694–702. PMID 12080043. doi:10.1074/jbc.M200266200.
Liu X, Tesfai J, Evrard YA, Dent SY, Martinez E (maio de 2003). "c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation". The Journal of Biological Chemistry 278 (22): 20405–12. PMC 4031917. PMID 12660246. doi:10.1074/jbc.M211795200.
Mori K, Maeda Y, Kitaura H, Taira T, Iguchi-Ariga SM, Ariga H (novembro de 1998). "MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc". The Journal of Biological Chemistry 273 (45): 29794–800. PMID 9792694. doi:10.1074/jbc.273.45.29794.
Fujioka Y, Taira T, Maeda Y, Tanaka S, Nishihara H, Iguchi-Ariga SM, Nagashima K, Ariga H (novembro de 2001). "MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer". The Journal of Biological Chemistry 276 (48): 45137–44. PMID 11567024. doi:10.1074/jbc.M106127200.
Feng XH, Liang YY, Liang M, Zhai W, Lin X (xaneiro de 2002). "Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)". Molecular Cell 9 (1): 133–43. PMID 11804592. doi:10.1016/s1097-2765(01)00430-0.
Otsuki Y, Tanaka M, Kamo T, Kitanaka C, Kuchino Y, Sugimura H (febreiro de 2003). "Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts". The Journal of Biological Chemistry 278 (7): 5132–40. PMID 12446731. doi:10.1074/jbc.M206733200.
Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M (abril de 1995). "Transcriptional activation by Myc is under negative control by the transcription factor AP-2". The EMBO Journal 14 (7): 1508–19. PMC 398238. PMID 7729426. doi:10.1002/j.1460-2075.1995.tb07137.x.
Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, Alicie B, Howard GC, Cawthon B, Ess KC, Eischen CM, Zhao Z, Fesik SW, Tansey WP (maio de 2015). "Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC". Molecular Cell 58 (3): 440–52. PMC 4427524. PMID 25818646. doi:10.1016/j.molcel.2015.02.028.
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (decembro de 1993). "Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc". Science 262 (5141): 1889–92. Bibcode:1993Sci...262.1889S. PMID 8266081. doi:10.1126/science.8266081.
Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T, Bartek J, Massagué J, Hänel F, Eilers M (abril de 2001). "Repression of p15INK4b expression by Myc through association with Miz-1". Nature Cell Biology 3 (4): 392–9. PMID 11283613. doi:10.1038/35070076.
Peukert K, Staller P, Schneider A, Carmichael G, Hänel F, Eilers M (setembro de 1997). "An alternative pathway for gene regulation by Myc". The EMBO Journal 16 (18): 5672–86. PMC 1170199. PMID 9312026. doi:10.1093/emboj/16.18.5672.

ebi.ac.uk (Global: 4,422^nd place; Galician: 464^th place)

"PSICQUIC View". ebi.ac.uk. Consultado o 2019-05-02.

man.ac.uk (Global: low place; Galician: 3,330^th place)

Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, et al. (June 2016). "Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells". Nature 534 (7607): 341–6. Bibcode:2016Natur.534..341A. PMC 4913876. PMID 27281222. doi:10.1038/nature18288. ^{[Ligazón morta]}

myscience.org.uk (Global: low place; Galician: low place)

"Scientists identify drugs to target 'Achilles heel' of Chronic Myeloid Leukaemia cells". myScience. 2016-06-08. Arquivado dende o orixinal o 2018-07-27. Consultado o 2016-06-09.

nih.gov (Global: 5^th place; Galician: 2^nd place)

ncbi.nlm.nih.gov

"Myc". NCBI.
Finver SN, Nishikura K, Finger LR, Haluska FG, Finan J, Nowell PC, Croce CM (maio de 1988). "Sequence analysis of the Myc oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered". Proceedings of the National Academy of Sciences of the United States of America 85 (9): 3052–6. Bibcode:1988PNAS...85.3052F. PMC 280141. PMID 2834731. doi:10.1073/pnas.85.9.3052.
Carabet LA, Rennie PS, Cherkasov A (decembro de 2018). "Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches". International Journal of Molecular Sciences 20 (1): 120. PMC 6337544. PMID 30597997. doi:10.3390/ijms20010120.
Dang CV, Reddy EP, Shokat KM, Soucek L (agosto de 2017). "Drugging the 'undruggable' cancer targets". Nature Reviews. Cancer 17 (8): 502–508. PMC 5945194. PMID 28643779. doi:10.1038/nrc.2017.36.
Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (setembro de 2012). "c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells". Cell 151 (1): 68–79. PMC 3471363. PMID 23021216. doi:10.1016/j.cell.2012.08.033.
Gearhart J, Pashos EE, Prasad MK (outubro de 2007). "Pluripotency redux--advances in stem-cell research". The New England Journal of Medicine 357 (15): 1469–72. PMID 17928593. doi:10.1056/NEJMp078126.
Cotterman R, Jin VX, Krig SR, Lemen JM, Wey A, Farnham PJ, Knoepfler PS (decembro de 2008). "N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor". Cancer Research 68 (23): 9654–62. PMC 2637654. PMID 19047142. doi:10.1158/0008-5472.CAN-08-1961.
Rahl PB, Young RA (xaneiro de 2014). "MYC and transcription elongation". Cold Spring Harbor Perspectives in Medicine 4 (1): a020990. PMC 3869279. PMID 24384817. doi:10.1101/cshperspect.a020990.
Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R (xullo de 2007). "Non-transcriptional control of DNA replication by c-Myc". Nature 448 (7152): 445–51. Bibcode:2007Natur.448..445D. PMID 17597761. doi:10.1038/nature05953.
Denis N, Kitzis A, Kruh J, Dautry F, Corcos D (agosto de 1991). "Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc". Oncogene 6 (8): 1453–7. PMID 1886715.
Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984). "Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation". Cell 36 (2): 241–7. PMID 6692471. doi:10.1016/0092-8674(84)90217-4.
Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV (xullo de 2008). "Global regulation of nucleotide biosynthetic genes by c-Myc". PLOS ONE 3 (7): e2722. Bibcode:2008PLoSO...3.2722L. PMC 2444028. PMID 18628958. doi:10.1371/journal.pone.0002722.
Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG, Mathews CK, Shewach DS, Nikiforov MA (agosto de 2008). "Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells". Cell Cycle 7 (15): 2392–400. PMC 3744895. PMID 18677108. doi:10.4161/cc.6390.
Aughey GN, Grice SJ, Liu JL (febreiro de 2016). "The Interplay between Myc and CTP Synthase in Drosophila". PLOS Genetics 12 (2): e1005867. PMC 4759343. PMID 26889675. doi:10.1371/journal.pgen.1005867.
Clavería C, Giovinazzo G, Sierra R, Torres M (agosto de 2013). "Myc-driven endogenous cell competition in the early mammalian embryo". Nature 500 (7460): 39–44. Bibcode:2013Natur.500...39C. PMID 23842495. doi:10.1038/nature12389.
de Alboran IM, O'Hagan RC, Gärtner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA, Alt FW (xaneiro de 2001). "Analysis of C-MYC function in normal cells via conditional gene-targeted mutation". Immunity 14 (1): 45–55. PMID 11163229. doi:10.1016/S1074-7613(01)00088-7.
Mendell JT (abril de 2008). "miRiad roles for the miR-17-92 cluster in development and disease". Cell 133 (2): 217–22. PMC 2732113. PMID 18423194. doi:10.1016/j.cell.2008.04.001.
Conacci-Sorrell M, Ngouenet C, Eisenman RN (agosto de 2010). "Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation". Cell 142 (3): 480–93. PMC 2923036. PMID 20691906. doi:10.1016/j.cell.2010.06.037.
Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, Elledge SJ, Westbrook TF (xaneiro de 2012). "A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis". Science 335 (6066): 348–53. Bibcode:2012Sci...335..348K. PMC 4059214. PMID 22157079. doi:10.1126/science.1212728. Erro no estilo Vancouver: wikilink (Axuda)
Ross JS, Ali SM, Wang K, Palmer G, Yelensky R, Lipson D, Miller VA, Zajchowski D, Shawver LK, Stephens PJ (setembro de 2013). "Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies". Gynecologic Oncology 130 (3): 554–9. PMID 23791828. doi:10.1016/j.ygyno.2013.06.019.
Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV, Buchanan S, Peng SB, Staschke KA, Yadav V, Yue Y, Kouros-Mehr H (2014). "Identification of druggable cancer driver genes amplified across TCGA datasets". PLOS ONE 9 (5): e98293. Bibcode:2014PLoSO...998293C. PMC 4038530. PMID 24874471. doi:10.1371/journal.pone.0098293.
Land H, Parada LF, Weinberg RA (1983). "Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes". Nature 304 (5927): 596–602. Bibcode:1983Natur.304..596L. PMID 6308472. doi:10.1038/304596a0.
Radner H, el-Shabrawi Y, Eibl RH, Brüstle O, Kenner L, Kleihues P, Wiestler OD (1993). "Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose". Acta Neuropathologica 86 (5): 456–65. PMID 8310796. doi:10.1007/bf00228580.
Fowler T, Ghatak P, Price DH, Conaway R, Conaway J, Chiang CM, Bradner JE, Shilatifard A, Roy AL (2014). "Regulation of MYC expression and differential JQ1 sensitivity in cancer cells". PLOS ONE 9 (1): e87003. Bibcode:2014PLoSO...987003F. PMC 3900694. PMID 24466310. doi:10.1371/journal.pone.0087003.
Shi J, Vakoc CR (xuño de 2014). "The mechanisms behind the therapeutic activity of BET bromodomain inhibition". Molecular Cell 54 (5): 728–36. PMC 4236231. PMID 24905006. doi:10.1016/j.molcel.2014.05.016.
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (September 2011). "BET bromodomain inhibition as a therapeutic strategy to target c-Myc". Cell 146 (6): 904–17. PMC 3187920. PMID 21889194. doi:10.1016/j.cell.2011.08.017.
Stasevich EM, Murashko MM, Zinevich LS, Demin DE, Schwartz AM (xullo de 2021). "The Role of Non-Coding RNAs in the Regulation of the Proto-Oncogene MYC in Different Types of Cancer". Biomedicines 9 (8): 921. PMC 8389562. PMID 34440124. doi:10.3390/biomedicines9080921.
Slizynska H (maio de 1938). "Salivary Chromosome Analysis of the White-Facet Region of Drosophila Melanogaster". Genetics 23 (3): 291–9. PMC 1209013. PMID 17246888. doi:10.1093/genetics/23.3.291.
de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA (abril de 2004). "Drosophila myc regulates organ size by inducing cell competition". Cell 117 (1): 107–16. PMID 15066286. doi:10.1016/S0092-8674(04)00214-4.
Maines JZ, Stevens LM, Tong X, Stein D (febreiro de 2004). "Drosophila dMyc is required for ovary cell growth and endoreplication". Development 131 (4): 775–86. PMID 14724122. doi:10.1242/dev.00932.
Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P (setembro de 1999). "Drosophila myc regulates cellular growth during development" (PDF). Cell 98 (6): 779–90. PMID 10499795. doi:10.1016/S0092-8674(00)81512-3. Arquivado dende o orixinal (PDF) o 03 de abril de 2022. Consultado o 13 de setembro de 2023.
Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, et al. (June 2016). "Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells". Nature 534 (7607): 341–6. Bibcode:2016Natur.534..341A. PMC 4913876. PMID 27281222. doi:10.1038/nature18288. ^{[Ligazón morta]}
Knoepfler PS, Cheng PF, Eisenman RN (outubro de 2002). "N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation". Genes & Development 16 (20): 2699–712. PMC 187459. PMID 12381668. doi:10.1101/gad.1021202.
Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, et al. (novembro de 2004). "c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation". Genes & Development 18 (22): 2747–63. PMC 528895. PMID 15545632. doi:10.1101/gad.313104.
Takahashi K, Yamanaka S (marzo de 2016). "A decade of transcription factor-mediated reprogramming to pluripotency". Nature Reviews. Molecular Cell Biology 17 (3): 183–93. PMID 26883003. doi:10.1038/nrm.2016.8.
Park J, Wood MA, Cole MD (marzo de 2002). "BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation". Molecular and Cellular Biology 22 (5): 1307–16. PMC 134713. PMID 11839798. doi:10.1128/mcb.22.5.1307-1316.2002.
Li H, Lee TH, Avraham H (xuño de 2002). "A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer". The Journal of Biological Chemistry 277 (23): 20965–73. PMID 11916966. doi:10.1074/jbc.M112231200.
Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM (decembro de 2003). "BRCA1 inhibition of telomerase activity in cultured cells". Molecular and Cellular Biology 23 (23): 8668–90. PMC 262673. PMID 14612409. doi:10.1128/mcb.23.23.8668-8690.2003.
Zhou C, Liu J (marzo de 2003). "Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells". Biochemical and Biophysical Research Communications 303 (1): 130–6. PMID 12646176. doi:10.1016/s0006-291x(03)00318-8.
Wang Q, Zhang H, Kajino K, Greene MI (outubro de 1998). "BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells". Oncogene 17 (15): 1939–48. PMID 9788437. doi:10.1038/sj.onc.1202403.
Jin Z, Gao F, Flagg T, Deng X (setembro de 2004). "Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation". The Journal of Biological Chemistry 279 (38): 40209–19. PMID 15210690. doi:10.1074/jbc.M404056200.
Kanazawa S, Soucek L, Evan G, Okamoto T, Peterlin BM (agosto de 2003). "c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis". Oncogene 22 (36): 5707–11. PMID 12944920. doi:10.1038/sj.onc.1206800.
Dingar D, Kalkat M, Chan PK, Srikumar T, Bailey SD, Tu WB, Coyaud E, Ponzielli R, Kolyar M, Jurisica I, Huang A, Lupien M, Penn LZ, Raught B (abril de 2015). "BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors". Journal of Proteomics 118 (12): 95–111. PMID 25452129. doi:10.1016/j.jprot.2014.09.029.
Brenner C, Deplus R, Didelot C, Loriot A, Viré E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T, Pelicci PG, Amati B, Kouzarides T, de Launoit Y, Di Croce L, Fuks F (xaneiro de 2005). "Myc represses transcription through recruitment of DNA methyltransferase corepressor". The EMBO Journal 24 (2): 336–46. PMC 545804. PMID 15616584. doi:10.1038/sj.emboj.7600509.
Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM (agosto de 2001). "The p400 complex is an essential E1A transformation target". Cell 106 (3): 297–307. PMID 11509179. doi:10.1016/s0092-8674(01)00450-0.
Roy AL, Carruthers C, Gutjahr T, Roeder RG (setembro de 1993). "Direct role for Myc in transcription initiation mediated by interactions with TFII-I". Nature 365 (6444): 359–61. Bibcode:1993Natur.365..359R. PMID 8377829. doi:10.1038/365359a0.
Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B (xuño de 2003). "MYC recruits the TIP60 histone acetyltransferase complex to chromatin". EMBO Reports 4 (6): 575–80. PMC 1319201. PMID 12776177. doi:10.1038/sj.embor.embor861.
Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT (xaneiro de 2008). "Widespread microRNA repression by Myc contributes to tumorigenesis". Nature Genetics 40 (1): 43–50. PMC 2628762. PMID 18066065. doi:10.1038/ng.2007.30.
Koscianska E, Baev V, Skreka K, Oikonomaki K, Rusinov V, Tabler M, Kalantidis K (2007). "Prediction and preliminary validation of oncogene regulation by miRNAs". BMC Molecular Biology 8: 79. PMC 2096627. PMID 17877811. doi:10.1186/1471-2199-8-79.
Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ, Antsaklis AI, Baxevanis CN, Papamichail M (maio de 2005). "CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells". The Journal of Biological Chemistry 280 (20): 20086–93. PMID 15769738. doi:10.1074/jbc.M410036200.
Gupta S, Davis RJ (outubro de 1994). "MAP kinase binds to the NH2-terminal activation domain of c-Myc". FEBS Letters 353 (3): 281–5. PMID 7957875. doi:10.1016/0014-5793(94)01052-8.
Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (xullo de 1997). "Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase". Proceedings of the National Academy of Sciences of the United States of America 94 (14): 7337–42. Bibcode:1997PNAS...94.7337T. PMC 23822. PMID 9207092. doi:10.1073/pnas.94.14.7337.
Noguchi K, Kitanaka C, Yamana H, Kokubu A, Mochizuki T, Kuchino Y (novembro de 1999). "Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase". The Journal of Biological Chemistry 274 (46): 32580–7. PMID 10551811. doi:10.1074/jbc.274.46.32580.
Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology 3: 89. PMC 1847948. PMID 17353931. doi:10.1038/msb4100134.
McMahon SB, Wood MA, Cole MD (xaneiro de 2000). "The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc". Molecular and Cellular Biology 20 (2): 556–62. PMC 85131. PMID 10611234. doi:10.1128/mcb.20.2.556-562.2000.
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD (agosto de 1998). "The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins". Cell 94 (3): 363–74. PMID 9708738. doi:10.1016/s0092-8674(00)81479-8.
Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV (maio de 1999). "c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function". Nature Genetics 22 (1): 102–5. PMID 10319872. doi:10.1038/8811.
Mac Partlin M, Homer E, Robinson H, McCormick CJ, Crouch DH, Durant ST, Matheson EC, Hall AG, Gillespie DA, Brown R (febeiro de 2003). "Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX". Oncogene 22 (6): 819–25. PMID 12584560. doi:10.1038/sj.onc.1206252.
Blackwood EM, Eisenman RN (marzo de 1991). "Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc". Science 251 (4998): 1211–7. Bibcode:1991Sci...251.1211B. PMID 2006410. doi:10.1126/science.2006410.
Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP (outubro de 2002). "JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors". Proceedings of the National Academy of Sciences of the United States of America 99 (22): 14189–94. Bibcode:2002PNAS...9914189L. PMC 137859. PMID 12391307. doi:10.1073/pnas.232310199.
Billin AN, Eilers AL, Queva C, Ayer DE (decembro de 1999). "Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors". The Journal of Biological Chemistry 274 (51): 36344–50. PMID 10593926. doi:10.1074/jbc.274.51.36344.
Gupta K, Anand G, Yin X, Grove L, Prochownik EV (marzo de 1998). "Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc". Oncogene 16 (9): 1149–59. PMID 9528857. doi:10.1038/sj.onc.1201634.
Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Lo Nigro C, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A, Carrozzo R (maio de 1997). "Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor". The EMBO Journal 16 (10): 2892–906. PMC 1169897. PMID 9184233. doi:10.1093/emboj/16.10.2892.
Nair SK, Burley SK (xaneiro de 2003). "X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors". Cell 112 (2): 193–205. PMID 12553908. doi:10.1016/s0092-8674(02)01284-9.
FitzGerald MJ, Arsura M, Bellas RE, Yang W, Wu M, Chin L, Mann KK, DePinho RA, Sonenshein GE (abril de 1999). "Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc". Oncogene 18 (15): 2489–98. PMID 10229200. doi:10.1038/sj.onc.1202611.
Meroni G, Cairo S, Merla G, Messali S, Brent R, Ballabio A, Reymond A (xullo de 2000). "Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?". Oncogene 19 (29): 3266–77. PMID 10918583. doi:10.1038/sj.onc.1203634.
Guo Q, Xie J, Dang CV, Liu ET, Bishop JM (agosto de 1998). "Identification of a large Myc-binding protein that contains RCC1-like repeats". Proceedings of the National Academy of Sciences of the United States of America 95 (16): 9172–7. Bibcode:1998PNAS...95.9172G. PMC 21311. PMID 9689053. doi:10.1073/pnas.95.16.9172.
Taira T, Maëda J, Onishi T, Kitaura H, Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H (agosto de 1998). "AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC". Genes to Cells 3 (8): 549–65. PMID 9797456. doi:10.1046/j.1365-2443.1998.00206.x.
Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K (abril de 2001). "Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor". Journal of Cell Science 114 (Pt 8): 1533–44. PMID 11282029. doi:10.1242/jcs.114.8.1533.
Taira T, Sawai M, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H (agosto de 1999). "Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y". The Journal of Biological Chemistry 274 (34): 24270–9. PMID 10446203. doi:10.1074/jbc.274.34.24270.
Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M, Yasumoto K, Funa K, Kohno K (agosto de 2002). "p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression". The Journal of Biological Chemistry 277 (35): 31694–702. PMID 12080043. doi:10.1074/jbc.M200266200.
Liu X, Tesfai J, Evrard YA, Dent SY, Martinez E (maio de 2003). "c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation". The Journal of Biological Chemistry 278 (22): 20405–12. PMC 4031917. PMID 12660246. doi:10.1074/jbc.M211795200.
Mori K, Maeda Y, Kitaura H, Taira T, Iguchi-Ariga SM, Ariga H (novembro de 1998). "MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc". The Journal of Biological Chemistry 273 (45): 29794–800. PMID 9792694. doi:10.1074/jbc.273.45.29794.
Fujioka Y, Taira T, Maeda Y, Tanaka S, Nishihara H, Iguchi-Ariga SM, Nagashima K, Ariga H (novembro de 2001). "MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer". The Journal of Biological Chemistry 276 (48): 45137–44. PMID 11567024. doi:10.1074/jbc.M106127200.
Feng XH, Liang YY, Liang M, Zhai W, Lin X (xaneiro de 2002). "Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)". Molecular Cell 9 (1): 133–43. PMID 11804592. doi:10.1016/s1097-2765(01)00430-0.
Otsuki Y, Tanaka M, Kamo T, Kitanaka C, Kuchino Y, Sugimura H (febreiro de 2003). "Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts". The Journal of Biological Chemistry 278 (7): 5132–40. PMID 12446731. doi:10.1074/jbc.M206733200.
Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M (abril de 1995). "Transcriptional activation by Myc is under negative control by the transcription factor AP-2". The EMBO Journal 14 (7): 1508–19. PMC 398238. PMID 7729426. doi:10.1002/j.1460-2075.1995.tb07137.x.
Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, Alicie B, Howard GC, Cawthon B, Ess KC, Eischen CM, Zhao Z, Fesik SW, Tansey WP (maio de 2015). "Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC". Molecular Cell 58 (3): 440–52. PMC 4427524. PMID 25818646. doi:10.1016/j.molcel.2015.02.028.
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (decembro de 1993). "Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc". Science 262 (5141): 1889–92. Bibcode:1993Sci...262.1889S. PMID 8266081. doi:10.1126/science.8266081.
Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T, Bartek J, Massagué J, Hänel F, Eilers M (abril de 2001). "Repression of p15INK4b expression by Myc through association with Miz-1". Nature Cell Biology 3 (4): 392–9. PMID 11283613. doi:10.1038/35070076.
Peukert K, Staller P, Schneider A, Carmichael G, Hänel F, Eilers M (setembro de 1997). "An alternative pathway for gene regulation by Myc". The EMBO Journal 16 (18): 5672–86. PMC 1170199. PMID 9312026. doi:10.1093/emboj/16.18.5672.

reuters.com (Global: 38^th place; Galician: 97^th place)

Begley S (2013-01-09). "DNA pioneer James Watson takes aim at cancer establishments". Reuters.

uzh.ch (Global: 1,380^th place; Galician: 1,523^rd place)

zora.uzh.ch

Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P (setembro de 1999). "Drosophila myc regulates cellular growth during development" (PDF). Cell 98 (6): 779–90. PMID 10499795. doi:10.1016/S0092-8674(00)81512-3. Arquivado dende o orixinal (PDF) o 03 de abril de 2022. Consultado o 13 de setembro de 2023.

web.archive.org (Global: 1^st place; Galician: 1^st place)

Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P (setembro de 1999). "Drosophila myc regulates cellular growth during development" (PDF). Cell 98 (6): 779–90. PMID 10499795. doi:10.1016/S0092-8674(00)81512-3. Arquivado dende o orixinal (PDF) o 03 de abril de 2022. Consultado o 13 de setembro de 2023.
"Scientists identify drugs to target 'Achilles heel' of Chronic Myeloid Leukaemia cells". myScience. 2016-06-08. Arquivado dende o orixinal o 2018-07-27. Consultado o 2016-06-09.

Myc (Galician Wikipedia)

adsabs.harvard.edu (Global: 14th place; Galician: 17th place)

archive.org (Global: 6th place; Galician: 4th place)

doi.org (Global: 2nd place; Galician: 3rd place)

dx.doi.org

ebi.ac.uk (Global: 4,422nd place; Galician: 464th place)

man.ac.uk (Global: low place; Galician: 3,330th place)